Presentation TCT 2023 TCT 528: Procedural Complications and Outcomes in Patients with Hypertrophic Obstructive Cardiomyopathy Undergoing Septal Myomectomy Versus Alcohol Septal Ablation. Presenter: Steven Imburgio October 26, 2023
Presentation TCT 2023 TCT 491: Diabetes mellitus as an independent risk for death and stroke in hypertrophic cardiomyopathy Presenter: Said hajouli October 26, 2023
Presentation TCT 2023 TCT 437: Transbrachial Right Ventricular Endomyocardial Biopsy – A Patient-Preferred Method Presenter: Dena Hayes October 26, 2023
Presentation TCT 2023 TCT 421: Permanent Pacemaker Following Alcohol Septal Ablation – Prevalence of Utilization at 1 Year? Presenter: Michael Bashline October 26, 2023
Presentation TCT 2023 TCT 306: Impact of Cardiac Amyloidosis in Patients with Severe Aortic Stenosis Undergoing Transcatheter and Surgical Aortic Valve Replacement: A Systematic Review and Meta-Analysis. Presenter: Muhammad Junaid Ahsan October 26, 2023
News Conference News ESC 2023 ESC Cardiomyopathy Guidelines Span Range of Phenotypes By Yael L. Maxwell August 31, 2023
News Conference News HFSA 2022 REDWOOD-HCM OLE: Aficamten Improves Patient-Measured Health Status By L.A. McKeown October 07, 2022
News Daily News FDA Approves Mavacamten for Obstructive Hypertrophic Cardiomyopathy By Michael O'Riordan April 29, 2022
News Conference News ACC 2022 Mavacamten Yields Stable Benefits in Obstructive HCM Over Longer Term By Shelley Wood April 03, 2022
News Daily News AI-Based Tool IDs Hypertrophic Cardiomyopathy and Cardiac Amyloidosis By Yael L. Maxwell February 24, 2022